Stock PIII P3 HEALTH PARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus P3 Health Partners Inc.

Equities

PIII

US7444131053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
0.6 USD +19.52% Intraday chart for P3 Health Partners Inc. -0.02% -57.45%
May. 22 P3 Health Partners Inc. announced that it expects to receive $42.2598 million in funding from Chicago Pacific Founders CI
May. 08 Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q1 Revenue $388.5M, vs. Street Est of $357.2M MT

Evolution of the average Target Price on P3 Health Partners Inc.

Price target over the last 5 years

History of analyst recommendation changes

52703ae.xlildoe8vFPFtxC8wU6O-9gQuZUKl-UU9JQWjo4MSCw.nyzGBu718wmP1UiFlgLhvJZ6-sxbx9Uijf9xz791fB3yaJEPxuXRN_aGSQ~b7382cbcffd9bc2c5627ddd1207132b2

Analyst Recommendations on P3 Health Partners Inc.

BTIG Research Downgrades P3 Health Partners to Neutral From Buy MT
Lake Street Adjusts Price Target on P3 Health Partners to $4.50 From $9, Maintains Buy Rating MT
In wait-and-see mode Our Logo
BTIG Initiates P3 Health Partners With Buy Rating, Price Target is $5 MT
TD Cowen Initiates P3 Health Partners at Market Perform MT
William Blair Initiates P3 Health Partners at Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.6 USD
Average target price
2.7 USD
Spread / Average Target
+350.00%
High Price Target
4.5 USD
Spread / Highest target
+650.00%
Low Price Target
0.9 USD
Spread / Lowest Target
+50.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering P3 Health Partners Inc.

BTIG
Lake Street
TD Cowen
William Blair & Co.

Ratings for P3 Health Partners Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PIII Stock
  4. Consensus P3 Health Partners Inc.